Stage IIC Melanoma
6 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery (NCT01748747) | Mayo Clinic | 2012-10-01 |
| Sargramostim or Hypertonic Saline Before Sentinel Lymph Node Biopsy in Treating Patients With Stage IB-II Melanoma (NCT01826864) | Jonsson Comprehensive Cancer Center | 2011-08-05 |
| Saracatinib in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery (NCT00669019) | National Cancer Institute (NCI) | 2006-07-01 |
| Vaccine Therapy With or Without Sargramostim in Treating Patients Who Have Undergone Surgery for Melanoma (NCT00089063) | National Cancer Institute (NCI) | 2004-06-01 |
| Vaccine Therapy in Treating Patients With Stage IIC-IV Melanoma (NCT00085189) | University of Southern California | 2004-05-01 |
| Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma (NCT00003895) | National Cancer Institute (NCI) | 1999-04-01 |
Track Stage IIC Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.